MetLife Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $69.6K | Sell |
|
|||||
|
2024
Q3 | $125K | Hold |
|
|||||
|
2024
Q2 | $139K | Buy |
|
|||||
|
2024
Q1 | $484K | Hold |
|
|||||
|
2023
Q4 | $465K | Hold |
|
|||||
|
2023
Q3 | $616K | Buy |
|
|||||
|
2023
Q2 | $721K | Buy |
|
|||||
|
2023
Q1 | $429K | Hold |
|
|||||
|
2022
Q4 | $502K | Hold |
|
|||||
|
2022
Q3 | $540K | Buy |
|
|||||
|
2022
Q2 | $553K | Hold |
|
|||||
|
2022
Q1 | $907K | Buy |
|
|||||
|
2021
Q4 | $1.05M | Hold |
|
|||||
|
2021
Q3 | $835K | Buy |
|
|||||
|
2021
Q2 | $630K | Hold |
|
|||||
|
2021
Q1 | $514K | Hold |
|
|||||
|
2020
Q4 | $615K | Buy |
|
|||||
|
2020
Q3 | $166K | Sell |
|
|||||
|
2020
Q2 | $488K | Buy |
|